The problem with that ‘negotiation’ is that the federal government is a monopoly, and the drug companies don’t have much choice.
And you seem to think that the drug companies are making so much profit that you can force them to drop prices with no consequence to R&D, innovation, etc.
Pharma profit statistics are perfect for abuse by partisans. Pharma comoanies invest billions in drug trials, and a single failed trial can sink a company. And if there is a success, the marginal cost of production is low so it looks like big profits if you don’t take into account the R&D costs of not just that drug, but of all the failed drug trials. So if you want to show ‘excess profits’, just pick a year where a drug passed its trials and went to market, but don’t average it with the years of investment it took to get there or with the years of losses when drug trials failed.
If you are an investor, if two investments return the same profit but one has higher risk, you will choose the lower risk investment every time. So in high volatility industries like pharma, profit margins have to be higher to pay for the risk premium.
When you factor it all in, Pharma doesn’t do any better than any other industry sector.
So what do you think will happen if you force drug prices lower? I can tell you: Some drugs will become unprofitable and research into them stopped. Pharma companies will focus more on boner pills and hair and weight loss medications, as those have huge markets. Treatment for your rare condition? Forget it.
If you want to lower the cost of drugs, figure out how to lower the cost of certification or extend patent life. Start by repealing the Kefauver amendments to the Pure Food and Drug Act mandating tests for efficacy. Test for safety only, then let doctors use their judgment. That would cut down the time to market for new drugs without impacting safety, which would drop prices substantially.
Also, end consumer marketing of prescription drugs (“ask your doctor about”), and criminalize drug kickbacks to doctors. Drug companies push doctors very hard to prescribe the latest, most expensive drugs when other much cheaper alternatives are available.